Latest Breaking News On - Regulus therapeutics - Page 2 : comparemela.com

Regulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest Down 32.9% in April

Regulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest Down 32.9% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states
Regulus-therapeutics-inc
Vanguard-group-inc
Vivo-capital
Wells-fargo-company
Regulus-therapeutics-company-profile
Victory-capital-management-inc
Canaccord-genuity-group
Nasdaq
Regulus-therapeutics
Get-free-report

RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024

RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Regulus-therapeutics
Place-earnings

Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at HC Wainwright

Regulus Therapeutics (NASDAQ:RGLS) Given "Buy" Rating at HC Wainwright
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

United-states
Leerink-partnrs
Victory-capital-management-inc
Wells-fargo-company
Regulus-therapeutics-inc
Canaccord-genuity-group
Vivo-capital
Regulus-therapeutics
Get-free-report
Genuity-group
Therapeutics-stock-down
Capital-management

Regulus Therapeutics (NASDAQ:RGLS) Given Buy Rating at HC Wainwright

Regulus Therapeutics (NASDAQ:RGLS) Given Buy Rating at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
Leerink-partnrs
Canaccord-genuity-group
Regulus-therapeutics-company-profile
Victory-capital-management-inc
Wells-fargo-company
Regulus-therapeutics-inc
Vivo-capital
Regulus-therapeutics
Free-report
Moderate-buy
Therapeutics-stock-down

Regulus Therapeutics (NASDAQ:RGLS) Receives "Buy" Rating from HC Wainwright

Regulus Therapeutics (NASDAQ:RGLS) Receives "Buy" Rating from HC Wainwright
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states
Leerink-partnrs
Victory-capital-management-inc
Regulus-therapeutics-company-profile
Wells-fargo-company
Canaccord-genuity-group
Vivo-capital
Regulus-therapeutics-inc
Regulus-therapeutics
Free-report
Genuity-group
Moderate-buy